Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 47   

Articles published

AZN 4,175.04 -14.96 (-0.36%)
price chart
AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire
Feb. 2 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second-biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.
AstraZeneca Plans to Cut 7300 Jobs  Wall Street Journal
AstraZeneca closing Montreal R&D plant  Globe and Mail
Europe Job Losses Accelerate With AstraZeneca-to-PepsiCo Firing Employees
13 (Bloomberg) -- Global companies from NEC Corp. to PepsiCo Inc. and AstraZeneca Plc are chopping jobs more than three times faster than in 2011 as they brace for recession in Europe and a slowdown in China.
Pfizer, AstraZeneca face revenue drop as patent protection expires
Pfizer Canada Inc. lost its bid to block the production of a generic eye drug by Apotex Inc. when the Supreme Court of Canada declined Thursday to hear the company's appeal.
Making the right exit: Lessons learned from AstraZeneca and IBM
The MSA also contained an obligation on AstraZeneca to produce an IT transfer plan for IBM detailing how the services would be transferred away from IBM.
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
Feb. 9 (Bloomberg) -- AstraZeneca Plc lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Vodafone and Visa announce global tie-up
Greece nerves trip FTSE 100 · 4 Stocks That Are Trading Far, Far Too Cheaply: AstraZeneca plc, Old Mutual plc, Aberdeen Asset Management plc And Rolls-Royce Holding PLC · Insider: Wikipedia founder buys People's Operator, Unite Group · More articles ...
Thomas Cook holding market share against rival TUI
Travel group Thomas Cook (TCG) said it had managed to hold on to market share despite tough trading conditions, rebuffing comments by rival TUI Travel () which has said it is benefiting from its rival's difficulties.
Astra takes brand cancer drug straight to patients
AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.
Reckitt Benckiser shares boosted by outperformance
Shares in Reckitt Benckiser () moved higher as markets responded to its announcement that it had exceeded full-year targets for 2011 and posted a strategy to continue outperformance into 2012.
R&D in Quebec pharma industry continues to erode
PetroChina in shale deal China is moving ever deeper into Canada's energy industry with a deal by PetroChina Co. today to join Royal Dutch Shell PLC in a shale gas project in northeastern British Columbia. The company did not disclose the pricetag for ...